Three women have been named winners of the UK young scientist awards, the country’s largest unrestricted prize for young researchers, marking only the second time all...
On December 3–4, 2026 in Boston, Women’s HealthX (WoHX) will bring together 750 global leaders from pharma and biotech, hospitals and health systems, health insurers, employers,...
A study of 900,000-plus patients found frail men faced a higher one-year death risk after a heart attack, although severe frailty was more common in women....
Women with stage IV breast cancer found through screening had a 60 per cent chance of surviving 10 years after diagnosis, a study found. This compares...
By Women As One Welcome to Women Who Lead, a series highlighting inspiring women leaders in cardiology who are shaping the future of cardiovascular medicine. In...
Researchers have secured A$2.8m to test whether AI can better predict ovarian cancer survival and response to treatment. The grant will allow researchers to use AI...
Teijin Pharma and Aska Pharmaceutical have teamed up on small-molecule drugs research for gynaecological diseases, combining AI-led design with clinical tests. The collaboration pairs Teijin Pharma’s...
Almost 80 per cent of private weight loss jabs such as Mounjaro are prescribed to women, according to analysis of 113,630 patients. The analysis, covering private...
Harmful bacteria may worsen breast cancer by switching on an enzyme that damages DNA and helps tumours grow, researchers say. The study found that pathogenic bacteria...
WHIS, the flagship summit uniting leaders across the women’s health and healthcare innovation ecosystem, has just announced that the 2026 edition of the event will be...
